| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3233/JND-170217 |
| P8608 | Fatcat ID | release_g42kftf4ibhphah3fbfjj2aojy |
| P932 | PMC publication ID | 5467719 |
| P698 | PubMed publication ID | 28550268 |
| P50 | author | Kanneboyina Nagaraju | Q27662260 |
| Dean Burkin | Q56759871 | ||
| Heather Gordish-Dressman | Q57474854 | ||
| P2093 | author name string | Raffaella Willmann | |
| Qing Yu | |||
| Markus A Rüegg | |||
| Anne Rutkowski | |||
| Mahasweta Girgenrath | |||
| Pam M Van Ry | |||
| Cathleen Lutz | |||
| Vivian Cruz | |||
| Ayar Kumar | |||
| Caroline B M Coffey | |||
| Laurent Bogdanik | |||
| Sarina Meinen | |||
| P2860 | cites work | Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy | Q24308817 |
| Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice | Q24602606 | ||
| Prevalence of congenital muscular dystrophy in Italy: a population study | Q28256516 | ||
| Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency | Q28258826 | ||
| Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development | Q33557296 | ||
| An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. | Q34091913 | ||
| Promotion of plasma membrane repair by vitamin E. | Q35639232 | ||
| Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy | Q37091285 | ||
| Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models | Q37384623 | ||
| Consensus statement on standard of care for congenital muscular dystrophies | Q37552615 | ||
| Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy | Q37625936 | ||
| Mitochondria as possible pharmaceutical targets for the effects of vitamin E and its homologues in oxidative stress-related diseases | Q37903067 | ||
| Disruption of the lama2 gene in embryonic stem cells: laminin alpha 2 is necessary for sustenance of mature muscle cells | Q41032544 | ||
| Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. | Q42489627 | ||
| Inhibiting TGF-β activity improves respiratory function in mdx mice | Q42732727 | ||
| Impaired respiratory function in mdx and mdx/utrn(+/-) mice | Q42741029 | ||
| Histopathologic findings in the sacrocaudalis dorsalis medialis muscle of horses with vitamin E-responsive muscle atrophy and weakness | Q45006054 | ||
| Congenital muscular dystrophy with merosin deficiency | Q59281293 | ||
| Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations | Q61794269 | ||
| Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study | Q72274091 | ||
| Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin) | Q77894566 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 2 | |
| P921 | main subject | membrane protein | Q423042 |
| congenital disorder | Q727096 | ||
| muscular dystrophy | Q1137767 | ||
| congenital muscular dystrophy | Q1321884 | ||
| reproducibility | Q1425625 | ||
| fibrous protein | Q1976174 | ||
| animal disease model | Q64732998 | ||
| biomedical investigative technique | Q66648976 | ||
| P304 | page(s) | 115-126 | |
| P577 | publication date | 2017-05-24 | |
| P1433 | published in | Journal of neuromuscular diseases | Q27726242 |
| P1476 | title | Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy | |
| P478 | volume | 4 |
| Q95840621 | A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD |
| Q98464776 | Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models |
| Q91906240 | Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy |
| Q47345657 | Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. |
| Q90733720 | Mouse models for muscular dystrophies: an overview |
Search more.